September 8 Media Roundup

Comments

Join us at Medidata Symposium in Phoenix Oct. 17-19.

It starts in the petri dish. Researchers are finding cancer and hepatitis C drugs show promise against Zika.

A superbug is born. Two genes joined together could set off the rise of drug-resistant superbugs.

The Allen Institute for Artificial Intelligence is developing AI with a deeper understanding of how physical events unfold.

CRISPR takes on sickle cell disease. St. Jude scientists use gene editing to improve the health of red blood cells.

The Gettysburg battlefield is being used to ow.ly/8Z0h303Nop9ow.ly/8Z0h303Nop9.

Cells with memories. The MIT Department of Biological Engineering use DNA sequencing to record the complex histories of human cells.

Experimental treatment for Alzheimer's reduces plaques found in ​patients' brains.

From advances in tech to rise of electronic health records, "cognified care” is changing the healthcare paradigm.

Increases in cases of Guillain-Barré syndrome may signal that Zika is spreading.

Tracking DNA data has led archaeologists to a new theory on the origins of American colonization.

The unsung hero of the digital revolution: Kálmán's algorithm continues to shape tech.

School nurses serve as the eyes and ears of public health.

Using CRISPR to shrink tumors in mice.

“The unspoken stigma of loneliness” – research links loneliness to physical illness and cognitive decline.

The U.S. government’s National Eye Institute (NEI) is committing $12.4 million to fund technology-focused studies to reverse optic nerve damage. "Understanding factors that mediate the regeneration of neurons and the growth of axons is crucial for the development of breakthrough therapies for blinding diseases," NEI Director Dr. Paul Sieving says. 

Follow us on Twitter and LinkedIn for the latest in how technology is transforming life sciences.

About Author

Dan Poppy

Medidata Editorial Director